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Abstract
Non-typhoid Salmonella and Mycobacterium avium complex infections are part of the constellation of
infections seen with increasing frequency in patients with acquired immuned deficiency syndrome.
The incidence has reduced significantly since highly active antiretroviral therapy era, but their critical
nature is unchanged. The co-existence of these infections and the accompanied increased mortality is
presented in this case report.
Case presentation
A 29-year-old African American woman with AIDS (CD4
count of 8 cells/uL) presented with three weeks history of
weakness, non-bloody, non-mucoid diarrhea and esopha-
geal candidiasis. Diarrhea was associated with abdominal
cramp but no nausea, vomiting and fever. She also had
subjective weight loss, non productive cough and anorexia
due to difficulty with swallowing. She had no history of
recent travel, dietary change or antibiotic use. AIDS was
diagnosed two years prior to admission during a routine
screening. She had an unclear HIV treatment at the time
and multiple opportunistic infections including Pneumo-
cystis jiroveci pneumonia and oropharyngeal candidiasis.
She was non adherent to Mycobacterium avium and
pneumocystis prophylactic treatment.
On examination, she was chronically ill appearing,
emaciated but in no acute distress. The blood pressure
was 115/59 mmHg, pulse 129 beats per minute, respira-
tion 24 breaths per minute, and temperature 100 F,
saturation in room air was 99%.
Pertinent findings were marked pallor, extensive oral
thrush and massive hepato-splenomegaly (spleen was
8 cm from subcostal margin and liver was 6 cm). Rectal
examination was normal. Blood study showed white
count 6,000/uL, neutrophil 92%, lymphocyte 4.5%,
hemoglobin 7 g/dL, hematocrit 20%, reticulocyte count
was 4.39%, ferritin was 617 ng/ml, transferrin saturation
of 2.7%, folate 2.41 ng/ml and platelet count was
209,000/uL.
Serum chemistry was normal. The hepatic panel revealed
normal aspartate transaminase 26 U/L, normal alanine
transaminase 16 U/L, elevated alkaline phosphatase
662 U/L, total bilirubin of 0.7 mg/dL, direct bilirubin
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Hepatitis B and C serology was negative.
Blood culture was positive for Salmonella newport. Stool
culture also grew Salmonella species. Blood mycobacterium
culture was pending but blood mycology was negative.
Abdominal computed tomography (CT) scan with
contrast showed thickening of the wall of proximal
small bowel and ascending colon with massive
hepatosplenomegaly.
She was started on intravenous ciprofloxacin which was
planned for 6 weeks duration because of severity and
persistence of salmonella infection in AIDS patients.
Her hospital course was complicated by severe anemia
(hematocrit was 14%) attributed to multifactorial etiology
including nutritional, anemia of chronic disease and
hypersplenism which required 10 units of packed red
blood cells over two weeks. Patient refused bone marrow
biopsy. Splenectomy was considered but deferred because
she was a high surgical risk.
After three weeks of intravenous ciprofloxacin treatment,
blood and stool cultures were negative for salmonella and
the patient was discharged on oral ciprofloxacin. Anti-
retroviral therapy with tenofovir 300 mg/emtricitabine
200 mg and lopinavir 400 mg/ritonavir 100 mg had
been initiated as well as atovaquone, azithromycin for
pneumocystis and Mycobacterium avium prophylaxis
respectively.
She was recalled nine days later for positive Mycobacterium
avium complex in a blood culture that was pending at the
time of her discharge. On readmission she reported
unresolved diarrhea and abdominal cramp. Her vital
sign was blood pressure of 70/50 mm of Hg, heart rate of
109 beat per minute, and temperature of 95.5 0F. She was
icteric with marked pallor. Laboratory data showed
pancytopenia (hemoglobin 6 g/dl, white cells 2,300/uL,
platelet count 16,000/uL) and metabolic acidosis. The
serum lactate dehydrogenase was 1542 IU/L and D-Dimer
was 3156.47. All cultures were repeated.
Abdominal CT scan with intravenous contrast showed
markedly enlarged spleen with multiple hypo dense
lesions, moderate ascites, thickened bowel loops, retro-
peritoneal and periportal lympadenopathy (Figure 1).
She was admitted into the intensive care unit (ICU) for
septic shock. Treatment for disseminated MAC was
initiated with rifabutin, ethambutol, azithromycin. Intra-
venous ciprofloxacin was continued for recurrent salmo-
nella gastroenteritis. Despite commencing appropriate
antimicrobial therapy, she expired on the third ICU day
from severe sepsis. Her family refused autopsy.
Discussion
Concomitant infection with Salmonella and Mycobacterium
avium complex as described in this case report is
uncommon. Our review of the literature confirmed the
rarity of a dual infection at any point in time. The
mechanisms that accounted for this dual infection is
linked to the uncontrolled HIV viremia with altered cell-
mediated immunity. Recurrent salmonella infection is an
AIDS defining illness that results from incomplete
clearance of the primary infection because of impaired
cell mediated immunity.
Usual clinical presentation is chronic non bloody diarrhea
with associated abdominal cramps. In the United States,
between 30 and 60% of HIV-infected patients have
diarrhea severe enough to require medical attention at
some time during the course of infection [1]. The
incidence of chronic diarrhea from all causes in patients
with CD4 < 200 cells/uL remain unchanged in the post
highly active antiretroviral therapy (HAART) era, ranging
from 8 to 10.5% per year [2].
Other important diarrhea causing enteric pathogens in
AIDS patients are CMV, Cryptosporidium, Microsporidium,
Entamoeba histolytica, Girdiasis, and Clostridium difficile
toxin.
Clinical features of MAC and Salmonella enteritis can be
very similar and confusing. Both pathogens are known to
Figure 1. Abdominal CT scan with intravenous contrast
showing hepatomegaly and enlarged spleen with multiple hypo
dense lesions.
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Non-typhoid Salmonella (NTS) infections are severe and
recurrent in HIV infected adults and are the commonest
cause of hospital admission with bacteremia in the Sub
Sahara Africa [3]. NTS bacteremia typically presents in
patients with AIDS once CD4 count falls below 200 cells/
uL. In-patient mortality can be up to 35-60% and is
highest in patients with severe anemia and confusion.
Other extra-intestinal manifestations of salmonellosis are
endocarditis, septic arthritis, pneumonia, abscess, pyo-
myositis, and pyelonephritis among others.
Among AIDS patient on HAART, the incidence of
Salmonella and other opportunistic infectious etiology
has declined from 53% to 13%, likely as a result of the
direct bactericidal activity of the HAART on Salmonella
species and immune reconstitution [2].
Definitive diagnosis of salmonellosis requires the isolation
of the organism from theblood, bone marrow, stool, urine
or intestinal secretions. The sensitivity of blood culture is
50-70%; so optimum approach to diagnosis is to culture
the blood, bone marrow and intestinal secretions which
have 90% yield for diagnosis. In the case described, the
patient had positive blood and stool for Salmonella.
Serology is not useful.
In contrast, disseminated Mycobacterium avium complex
(MAC) infection is a common complication of advanced
AIDS. It is established that MAC is associated with
shortened survival in AIDS causing a 3-fold increased
risk of death irrespective of CD4 count [4]. The increased
mortality may be explained by up-regulation of HIV RNA
and/or by direct effects of MAC.
Clinical manifestations include fever, weight loss, night
sweat, elevated LDH, elevated alkaline phosphatase and
anemia. Factors associated with developing MAC are
younger age and antiretroviral therapy naive [5]. Since
the advent of HAART, the rate of MAC infection has
declined substantially, but patients with low CD4 count
remain at risk. Current recommendation requires routine
use of chemoprophylaxis with azithromycin 1200 mg
weekly in patients with CD < 50 cells/uL and it can be
discontinued when CD4 count rises above 100 cells/uL on
two consecutive determinations in response to HAART
therapy [6]. Life long prophylaxis is recommended for
those with history of disseminated MAC without evidence
of immune reconstitution or HAART induced rise in CD4
cell count [7].
Diagnosis of MAC is made by isolating the organism from
culture of blood, lymph node, liver, spleen and bone
marrow (BM). The average duration of culturing depends
on the medium used but varies from 7-16 days. AFB
staining of BM aspirate is the least sensitive method but
results are available in a mean of 1.1 days [8]. In our case
culture came back after two weeks.
The standard treatment for disseminated MAC is by
combination pharmacotherapy using clarithromycin
500 mg bid, ethambutol 15 mg/kg/d and rifabutin
300 mg/d given indefinitely or until evidence of immune
reconstitution secondary to HAART. The United States
Public Health Service (USPHS) and Infectious Disease
Society of America (IDSA) guidelines state that at least
12 months of therapy and six months of immune
reconstitution. Azithromycin 600 mg daily can be used
in place of clarithromycin, but clarithromycin is the
preferred agent. Other treatment regimen exists.
To avoid treatment delay and poor outcome, clinicians
should begin empirical anti-MAC therapy once dissemi-
nated MAC is suspected. It should be remembered that a
rapid diagnosis using the BM aspirate AFB staining is
possible if patient consents.
In conclusion, the occurrence of multiple opportunistic
infections should be suspected in late stage AIDS because
dual infections will likely increase mortality. These
patients are at risk for multiple infections and therefore
other causes of a clinical syndrome should be sought even
if one cause has been identified, especially if the patient
does not improve. AIDS patients must be managed for
opportunistic infections and then initiate HAART when
feasible as severe immune reconstitution may also be life
threatening.
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